Registering a CAGR of 5.4% over the forecast period, the market value of Autotransfusion devices is expected to reach US$ 380 million in the year 2027.
An autotransfusion device is a mechanical device used to collect and re-infuse blood lost due to hemorrhage. Intra-operative, emergency, or post-operative salvage devices, as well as hemodilution devices used to re-infuse a patient's own blood, are examples of autotransfusion devices. The market for autotransfusion devices is expanding due to the increasing prevalence of orthopedic and cardiac surgery. Furthermore, as autotransfusion devices continue to evolve, the global autotransfusion device market is expanding.
The increasing number of surgical procedures, the increasing number of transplant procedures, the benefits of autotransfusion, and the scarcity of donated blood/allogeneic blood are driving the growth of this market. The rising number of surgical procedures around the world is expected to drive market growth during the forecast period. According to a CADI Research Foundation article, approximately 60,000 coronary bypass surgeries are performed in India each year. This is expected to drive market growth over the forecast period. Furthermore, the aging population, rising prevalence of chronic diseases, and increased demand for advanced blood management systems are expected to drive global market growth during the forecast period.
The report aspects discussed the profile of the top manufacturers of the global Autotransfusion Device market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined Autotransfusion Device Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
The global Autotransfusion Device includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Becton Dickinson and Co (NYSE: BDX), Brightwake Ltd., Fresenius (ETR: FRE), Getinge AB (STO: GETI-B), Haemonetics Corporation (NYSE: HAE), LivaNova PLC (NASDAQ: LIVN), Medtronic Plc. (NYSE: MDT), Stryker (NYSE: SYK) and others.
Apr. 20, 2021— LivaNova PLC (NASDAQ: LIVN) announced that it has received FDA 510(k) clearance for B-Capta®, the new in-line blood-gas monitoring system integrated into the market-leading S5® heart-lung machine (HLM). The system is intended to monitor arterial and venous blood gas parameters easily and accurately, even during long and complex pediatric and adult cardiopulmonary bypass procedures. B-Capta, which received CE Mark in May 2020 and completed a successful limited commercial release in Europe, will now be available globally.
April 8, 2019— BD (Becton, Dickinson, and Company) (NYSE: BDX), a global medical technology company, has announced the global availability of BD BACTECTM platelet quality control media, which enables microbiology laboratories, blood banks, and transfusion services to identify contaminated platelet units.
The market is segmented based on the type, applications, companies, and regions.
By Type, it is segmented into
By Application, it is segmented into
The high prevalence of cardiac devices is a factor that contributes to the global growth of the autotransfusion device market. Furthermore, the absence of any risk of transfusion or transmitting devices is a significant factor driving the growth of the autotransfusion devices market. Furthermore, the absence of the risk of alloimmunization to blood cells accelerates the growth of the autotransfusion devices market. The inability to separate contaminations from blood cells, on the other hand, is expected to stymie the growth of the autotransfusion Devices market. Increasing adoption of full-body transfusion devices, on the other hand, is expected to provide lucrative opportunities during the forecast period.
Throughout the forecast period, North America is expected to dominate the overall market. The presence of key players, a high number of surgeries in the region, and established healthcare infrastructure are some of the key factors responsible for its large market share. Furthermore, beneficial government initiatives and increased awareness of auto-transfusion due to a lack of allogenic blood in the region are expected to drive market growth. Because of supportive healthcare policies and a developed healthcare market, the United States has the largest share in this region.
The Autotransfusion Device Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Autotransfusion Device Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Scope of the Report covers the Autotransfusion Device Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Autotransfusion Device Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.
Report Attributes | Report Details |
Report Title | Autotransfusion Device Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Becton Dickinson and Co (NYSE: BDX), Fresenius (ETR: FRE), Getinge AB (STO: GETI-B), Stryker (NYSE: SYK) |
Forecast Period 2022 to 2027 CAGR | CAGR of 5.4% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Becton, Dickinson and Company, Brightwake Ltd., Fresenius, Getinge AB, Haemonetics Corporation, LivaNova PLC, Medtronic Plc., Stryker |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 97 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Autotransfusion Device Market is studied from 2017 - 2027.
What is the growth rate of the Autotransfusion Device Market?
The Autotransfusion Device Market is growing at a CAGR of 5.4% over the next 5 years.
Who are the key players in Autotransfusion Device Market?
Becton, Dickinson and Company, Brightwake Ltd., Fresenius, Getinge AB, Haemonetics Corporation, LivaNova PLC, Medtronic Plc., Stryker
What regions does this Autotransfusion Device Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Autotransfusion Device Market?
On-pump Transfusion Devices, Off-pump Transfusion Devices
What are the major end-use applications of Autotransfusion Device Market?
Hospitals, Ambulatory Surgical Centers, Others
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.